Dong Q - Search Results

1

Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma.

Wang S, Zhu L, Li T, Lin X, Zheng Y, Xu D, Guo Y, Zhang Z, Fu Y, Wang H, Wang X, Zou T, Shen X, Zhang L, Lai N, Lu L, Qin L, Dong Q. Wang S, et al. Among authors: dong q. Cell Rep Med. 2024 Feb 20;5(2):101415. doi: 10.1016/j.xcrm.2024.101415. Cell Rep Med. 2024. PMID: 38382467 Free PMC article.

2

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.

Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, Ren N, Qin LX. Sun BS, et al. Among authors: dong qz. Hepatology. 2008 Dec;48(6):1834-42. doi: 10.1002/hep.22531. Hepatology. 2008. PMID: 18972404

3

Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses.

Fu LY, Jia HL, Dong QZ, Wu JC, Zhao Y, Zhou HJ, Ren N, Ye QH, Qin LX. Fu LY, et al. BMC Cancer. 2009 Feb 6;9:49. doi: 10.1186/1471-2407-9-49. BMC Cancer. 2009. PMID: 19200351 Free PMC article.

4

The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.

Sun J, Xu HM, Zhou HJ, Dong QZ, Zhao Y, Fu LY, Hei ZY, Ye QH, Ren N, Jia HL, Qin LX. Sun J, et al. J Cancer Res Clin Oncol. 2010 Jan;136(1):1-7. doi: 10.1007/s00432-009-0629-x. J Cancer Res Clin Oncol. 2010. PMID: 19593583

5

[Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].

Zhao Y, Jia HL, Zhou HJ, Dong QZ, Fu LY, Yan ZW, Sun J, Ren N, Ye QH, Qin LX. Zhao Y, et al. Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):526-30. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19912688 Chinese.

6

Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection.

Huang H, Zhang XF, Zhou HJ, Xue YH, Dong QZ, Ye QH, Qin LX. Huang H, et al. Cancer Sci. 2010 May;101(5):1314-9. doi: 10.1111/j.1349-7006.2010.01524.x. Epub 2010 Feb 5. Cancer Sci. 2010. PMID: 20345480 Free PMC article.

7

Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma.

Xue YH, Zhang XF, Dong QZ, Sun J, Dai C, Zhou HJ, Ren N, Jia HL, Ye QH, Qin LX. Xue YH, et al. Hepatology. 2010 Dec;52(6):2012-22. doi: 10.1002/hep.23942. Epub 2010 Oct 1. Hepatology. 2010. PMID: 20890897

8

Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection.

Zhou H, Huang H, Shi J, Zhao Y, Dong Q, Jia H, Liu Y, Ye Q, Sun H, Zhu X, Fu L, Guo K, Gao D, Sun J, Yan Z, Ren N, Tang Z, Qin L. Zhou H, et al. Among authors: dong q. Gut. 2010 Dec;59(12):1699-708. doi: 10.1136/gut.2010.218404. Epub 2010 Oct 12. Gut. 2010. PMID: 20940284

9

Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.

Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ, Qin LX. Li GC, et al. Cancer Sci. 2010 Dec;101(12):2546-53. doi: 10.1111/j.1349-7006.2010.01738.x. Epub 2010 Oct 7. Cancer Sci. 2010. PMID: 20942864 Free PMC article.

10

Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma.

Dai C, Dong QZ, Ren N, Zhu JJ, Zhou HJ, Sun HJ, Wang G, Zhang XF, Xue YH, Jia HL, Ye QH, Qin LX. Dai C, et al. Cancer Sci. 2011 Mar;102(3):583-90. doi: 10.1111/j.1349-7006.2011.01863.x. Cancer Sci. 2011. PMID: 21219541 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,847 results

Search Page

Filters